Literature DB >> 14938068

Fatal aplastic anemia following chloramphenicol (chloromycetin) administration.

R K SMILEY, G E CARTWRIGHT, M M WINTROBE.   

Abstract

Entities:  

Keywords:  ANEMIA, APLASTIC/etiology and pathogenesis; CHLORAMPHENICOL/toxicity

Mesh：

Substances：

Year:  1952        PMID： 14938068     DOI： 10.1001/jama.1952.02930270008003

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  9 in total

1.  Chloramphenicol therapy: a warning.

Authors:  E KRIEGER
Journal:  Can Med Assoc J       Date:  1961-03-11       Impact factor: 8.262

2.  Persistence of antibiotics in blood of patients with acute renal failure. II. Chloramphenicol and its metabolic products in the blood of patients with severe renal disease or hepatic cirrhosis.

Authors:  C M KUNIN; A J GLAZKO; M FINLAND
Journal:  J Clin Invest       Date:  1959-09       Impact factor: 14.808

3.  The in-vitro sensitivity of H. influenzae to five different antibiotics.

Authors:  K ZINNEMANN
Journal:  Br Med J       Date:  1953-11-14

4.  Chloramphenicol treatment of the newborn.

Authors:  R M CALMAN; J MURRAY
Journal:  Br Med J       Date:  1953-04-04

5.  Maxwell Myer Wintrobe: new history and a new appreciation.

Authors:  Herbert L Fred
Journal:  Tex Heart Inst J       Date:  2007

6.  Fatal aplastic anaemia after chloramphenicol.

Authors:  B WOLMAN
Journal:  Br Med J       Date:  1952-08-23

7.  Susceptibility testing of anaerobic bacteria with 100-microg carbenicillin disks.

Authors:  W W Laslie; D W Lambe
Journal:  Antimicrob Agents Chemother       Date:  1976-07       Impact factor: 5.191

8.  Fatal aplastic anemia following chloramphenicol (chloromycetin) therapy.

Authors:  C WINTERNITZ
Journal:  Calif Med       Date:  1952-11

9.  Concentrations of ampicillin and chloramphenicol in the serum of patients with acute Salmonella enteric fever.

Authors:  I A Mikhail; D C Kent; K Sorensen; W R Sanborn; J Smith
Journal:  Antimicrob Agents Chemother       Date:  1972-11       Impact factor: 5.191
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.